Cherokee Regional Medical Center — Pricing
42 procedures published in this hospital's Machine-Readable File (MRF) — 42 with a comparable price, 0 with per-payer negotiated rates only. Prices shown are pre-insurance; actual cost depends on your plan, Medicare/Medicaid coverage, or cash-pay discounts.
Procedures published 42
Lowest published price $2,597
Average published price $12,828
Highest published price $67,738
Gross charges are the hospital's listed price — almost no one pays this amount. Your actual cost depends on your insurance plan. Use the cash price (when shown) as a guide for what uninsured patients are charged, and contact the hospital or your insurer for a personalized cost estimate.
Estimate your out-of-pocket cost
Enter what's left on your plan this year, then choose a procedure — click any row below or its “Estimate” button.
Leave blank if unsure — no cap will be applied.
No procedure selected yet — pick a row in the table below to see an estimate here.
Estimate only. Your plan's actual negotiated rate, network status, and benefit rules control what you pay — confirm with your insurer. Professional fees (surgeon, anesthesia) are usually billed separately.
Published charges
Showing all 42 procedures with a comparable published price (gross, cash, or insurance-negotiated median), sorted highest to lowest. Green = this hospital prices below the median; amber = above.
| DRG | Description | Published price | Cash price | vs. IA median | vs. National median | ||
|---|---|---|---|---|---|---|---|
| 467 | DRG REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $67,738 | $54,190 | $59,878 | +13% | $70,847 | −4% |
| 470 | Major joint replacement or reattachment of lower extremity without major comorbid conditions or complications (MCC). | $61,852 | $49,482 | $58,965 | +5% | $50,607 | +22% |
| 641 | DRG MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & P | $33,771 | $27,017 | $16,312 | +107% | $17,038 | +98% |
| 871 | DRG SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $23,615 | $18,892 | $24,382 | −3% | $35,628 | −34% |
| 330 | DRG MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | $20,584 | $16,467 | $74,535 | −72% | $59,500 | −65% |
| 536 | DRG FRACTURES OF HIP AND PELVIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $17,328 | $13,862 | $17,723 | −2% | $18,002 | −4% |
| 418 | DRG LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH COMPLICATION OR COMORBIDITY (CC) | $16,725 | $13,380 | $66,219 | −75% | $44,606 | −63% |
| 798 | DRG VAGINAL DELIVERY WITH STERILIZATION/D&C WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | $14,639 | $11,711 | $15,570 | −6% | $18,452 | −21% |
| 192 | DRG CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSI | $14,470 | $11,576 | $8,548 | +69% | $14,368 | +1% |
| 194 | DRG SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $14,440 | $11,552 | $17,777 | −19% | $18,204 | −21% |
| 788 | DRG CESAREAN SECTION WITHOUT STERILIZATION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | $14,415 | $11,532 | $19,013 | −24% | $20,084 | −28% |
| 787 | DRG CESAREAN SECTION WITHOUT STERILIZATION WITH COMPLICATION OR COMORBIDITY (CC) | $13,118 | $10,494 | $19,959 | −34% | $23,571 | −44% |
| 190 | DRG CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $11,305 | $9,044 | $21,475 | −47% | $24,386 | −54% |
| 202 | DRG BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | $11,152 | $8,922 | $9,491 | +18% | $17,724 | −37% |
| 387 | DRG INFLAMMATORY BOWEL DISEASE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | $10,653 | $8,522 | $37,463 | −72% | $16,288 | −35% |
| 637 | DRG DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | $10,276 | $8,221 | $25,497 | −60% | $30,100 | −66% |
| 291 | DRG HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $9,730 | $7,784 | $19,102 | −49% | $26,776 | −64% |
| 768 | DRG VAGINAL DELIVERY WITH O.R. PROCEDURE EXCEPT STERILIZATION AND/OR D&C - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $9,703 | $7,763 | $13,921 | −30% | $16,846 | −42% |
| 785 | DRG CESAREAN SECTION WITH STERILIZATION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | $9,433 | $7,546 | $17,664 | −47% | $19,846 | −52% |
| 690 | DRG KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | $9,394 | $7,515 | $12,946 | −27% | $17,674 | −47% |
| 727 | DRG INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $9,171 | $7,336 | $17,568 | −48% | $26,463 | −65% |
| 179 | DRG RESPIRATORY INFECTIONS AND INFLAMMATIONS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | $8,796 | $7,036 | $10,847 | −19% | $14,648 | −40% |
| 806 | DRG VAGINAL DELIVERY WITHOUT STERILIZATION/D&C WITH COMPLICATION OR COMORBIDITY (CC) | $8,598 | $6,878 | $10,947 | −21% | $13,275 | −35% |
| 189 | DRG PULMONARY EDEMA AND RESPIRATORY FAILURE - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $8,572 | $6,858 | $21,623 | −60% | $26,580 | −68% |
| 644 | DRG ENDOCRINE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | $8,553 | $6,842 | $44,407 | −81% | $23,198 | −63% |
| 158 | DRG DENTAL AND ORAL DISEASES WITH COMPLICATION OR COMORBIDITY (CC) | $7,876 | $6,301 | $11,933 | −34% | $18,466 | −57% |
| 603 | DRG CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $7,826 | $6,261 | $17,813 | −56% | $18,530 | −58% |
| 807 | DRG VAGINAL DELIVERY WITHOUT STERILIZATION/D&C WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | $7,600 | $6,080 | $10,333 | −26% | $12,078 | −37% |
| 195 | DRG SIMPLE PNEUMONIA AND PLEURISY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $7,475 | $5,980 | $8,123 | −8% | $13,824 | −46% |
| 640 | DRG MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | $7,248 | $5,798 | $27,526 | −74% | $25,463 | −72% |
| 191 | DRG CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $7,138 | $5,711 | $14,790 | −52% | $18,807 | −62% |
| 552 | DRG MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | $6,896 | $5,517 | $22,291 | −69% | $21,396 | −68% |
| 281 | DRG ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | $6,669 | $5,335 | $13,014 | −49% | $20,463 | −67% |
| 949 | DRG AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $6,309 | $5,047 | $15,037 | −58% | $23,953 | −74% |
| 392 | DRG ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIAN | $6,053 | $4,843 | $18,500 | −67% | $17,322 | −65% |
| 378 | DRG G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS | $5,640 | $4,512 | $31,379 | −82% | $22,098 | −74% |
| 897 | DRG ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | $5,174 | $4,140 | $19,393 | −73% | $16,699 | −69% |
| 793 | DRG FULL TERM NEONATE WITH MAJOR PROBLEMS | $4,821 | $3,857 | $15,127 | −68% | $18,649 | −74% |
| 064 | DRG INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | $4,773 | $3,819 | $31,381 | −85% | $39,106 | −88% |
| 794 | DRG NEONATE WITH OTHER SIGNIFICANT PROBLEMS | $3,425 | $2,740 | $8,633 | −60% | $8,445 | −59% |
| 203 | DRG BRONCHITIS AND ASTHMA WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | $3,236 | $2,589 | $8,559 | −62% | $12,252 | −74% |
| 795 | DRG NORMAL NEWBORN | $2,597 | $2,077 | $5,662 | −54% | $4,720 | −45% |